-
Company Insights
NewInnovation and Patenting activity of The Children~s Place Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of The Children~s Place Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Abacavir Sulfate + Lamivudine + Lopinavir + Ritonavir) in Human Immunodeficiency Virus (HIV) Infections (AIDS)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Abacavir Sulfate + Lamivudine + Lopinavir + Ritonavir) in Human Immunodeficiency Virus (HIV) Infections...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RGX-181 in Batten Disease
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. RGX-181 in Batten Disease Drug Details: RGX-181 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEEL-224 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEEL-224 in Solid Tumor Drug Details: PEEL-224 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gene Therapy to Target CD19 and CD22 for B-cell Acute Lymphoblastic Leukemia and Lymphoma in B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gene Therapy to Target CD19 and CD22 for B-cell Acute Lymphoblastic Leukemia and Lymphoma...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Primary Humoral Immune Deficiencies
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Primary Humoral Immune Deficiencies Drug Details: Human normal immunoglobulin (Globulin SN, Globulin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Tachycardia (Tachyarrhythmias)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Immune Globulin (Human) in Tachycardia (Tachyarrhythmias) Drug Details:Human Immunoglobulin G (also known as human normal immunoglobulin)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabozantinib S-malate in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cabozantinib S-malate in Gastric Cancer Drug Details: Cabozantinib s-malate (XL184, BMS907351, Cometriq) is a s-malate...
-
Sector Analysis
Hungary Apparel Market Overview and Trend Analysis by Category and Forecasts to 2027
This databook uses data from GlobalData’s Apparel database showing the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share in 2022 in each of the sectors as well as total apparel. This databook provides both the historic and forecast market data of total apparel sales in Hungary. It illustrates the data with charts, graphs and tables summarizing the value and volume trends, with category details in each sector. The forecasts...
-
Sector Analysis
Romania Apparel Market Overview and Trend Analysis by Category and Forecasts to 2027
This databook uses data from GlobalData’s Apparel database showing the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share in 2022 in each of the sectors as well as total apparel. This databook provides both the historic and forecast market data of total apparel sales in Romania. It illustrates the data with charts, graphs and tables summarizing the value and volume trends, with category details in each sector. The forecasts...